Active tuberculosis in inflammatory bowel disease patients: a case-control study.

"MFCA reports receiving consulting fees from Janssen and Takeda; lecture fees from Janssen, Takeda, Pfizer, and Abbvie; and travel grant support from Takeda, Janssen, and Abbvie. LLB reports receiving lecture fees from Janssen, Takeda, and UCB and travel grant support from Takeda and Janssen. ASC reports receiving lecture fees from Janssen, Takeda, and Abbvie and travel grant support from Takeda, Janssen, and Abbvie. NSFQ reports receiving consulting payments from Janssen, lecture fees from Janssen, Takeda, UCB, and Abbvie, and travel grant support from Takeda, Janssen, and Abbvie. AOMCD reports receiving lecture fees from Janssen, Takeda, and Abbvie and travel grant support from Takeda. JO, FFJ, KSG, CAM, AZAL, and AMS have no conflict of interest to declare. No other potential conflict of interest relevant to this letter was reported."

"Funding: The authors received no financial support for the research, authorship, and/or publication of this article."